Business Context and Reporting Period
Company: Applied Materials, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: January 26, 2003 (First Fiscal Quarter 2003)
Industry Context: Applied Materials supplies semiconductor manufacturing equipment. The company is navigating a severe, prolonged downturn in the semiconductor industry, characterized by reduced capital spending, inventory buildups in telecom, and slow global economic growth. Management believes this may be the most severe decline in the industry's history.
Key Financial Metrics
| Metric (in thousands) | Q1 2003 | Q1 2002 |
|---|---|---|
| Net Sales | $1,054,209 | $1,000,460 |
| Gross Margin | $390,382 (37.0%) | $385,452 (38.5%) |
| Operating Loss | ($117,179) | ($100,673) |
| Net Loss | ($65,670) | ($45,495) |
| Loss Per Share (Diluted) | ($0.04) | ($0.03) |
| Cash from Operations | $87,451 | $101,108 |
| Cash & Equivalents (End of Period) | $1,292,948 | $1,101,435 |
| Total Short-Term Investments | $3,695,986 | $3,644,735 |
| Total Debt (Current + Long-Term) | $623,648 | $623,629 |
Note: Debt figures derived from Balance Sheet (Notes Payable + Current Portion of Long-Term Debt + Long-Term Debt).
Material Changes vs. Prior Period
- Revenue: Net sales increased 5% year-over-year to $1.05 billion, driven primarily by a significant increase in sales to Korea ($170M vs $89M in Q1 2002). However, sales declined 27% sequentially from the previous quarter.
- Profitability: Net loss widened to $65.7 million from $45.5 million in the prior year quarter. Gross margin percentage declined to 37.0% from 38.5% due to underabsorption of manufacturing and field service costs resulting from lower volumes.
- Restructuring: The company recorded a pre-tax restructuring charge of $99 million ($0.04 per share) to reduce the global workforce by approximately 1,750 positions (11%) and consolidate facilities. This compares to $85 million in charges in Q1 2002.
- Orders and Backlog: New orders dropped 35% sequentially to $1.0 billion. Backlog decreased to $3.1 billion from $3.2 billion in the prior quarter.
- Liquidity: Despite the net loss, cash and cash equivalents increased slightly to $1.29 billion, supported by strong operating cash flow ($87M) and working capital management (reduction in accounts receivable and inventory).
Guidance, Outlook, and Risks
Management Commentary: Management does not provide specific numerical guidance for future quarters due to the unpredictability of the current industry downturn. They anticipate the recovery timing and growth rate remain uncertain. The company continues to execute cost reduction programs to align its cost structure with market conditions.
Key Risks and Contingencies:
- Industry Cyclicality: The semiconductor industry is highly volatile; the current downturn is described as potentially the most severe in history.
- Customer Concentration: A limited number of customers account for a substantial portion of sales, creating risk if orders are delayed or canceled.
- Legal Proceedings: The company is involved in multiple patent infringement lawsuits (e.g., Novellus, Axcelis, Linear Technology, Semitool, ASMI, Bosch). While management believes it has meritorious defenses, outcomes are uncertain and could result in significant costs or injunctions.
- Regulatory/Accounting: The company is assessing the impact of FASB Interpretation No. 46 (FIN 46) regarding the consolidation of its venture capital fund, Applied Materials Ventures I, L.P.
- Global Operations: Risks include political instability, trade restrictions, and currency fluctuations, particularly in Asia where a significant portion of revenue is generated.
Investor Verification Checklist
- Order Book Health: Verify the trend in new orders ($1.0B) and backlog ($3.1B) to gauge future revenue visibility given the 35% sequential drop in orders.
- Restructuring Execution: Monitor the actual cash outlays for the $99M restructuring charge and the effectiveness of the 11% workforce reduction in stabilizing operating expenses.
- Legal Exposure: Review the status of pending patent litigation (specifically Novellus and Axcelis trials scheduled for May 2003) for potential financial impact.
- Liquidity Runway: Confirm that the $4.99 billion in cash and short-term investments remains sufficient to fund operations and capital expenditures ($77M in Q1) without external financing during the prolonged downturn.
- Margin Pressure: Assess whether gross margins can stabilize at 37% or if further volume declines will force additional margin compression.